BEN YONG (Chief Med & Dev Officer) received a stock award from BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/12/2026ACC: 0001193125-26-104369
Officer· Chief Med & Dev Officer
Since Mar 2026
+256.67K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
256.67K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+46.67K
Price / share
—
Trade value
—
% of position
New position
3/10/2026
0.00→46.67K
Total
Net shares
+46.67K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/10/2026 | A · Award | +46.67K | — | — | New position | 0.00 | 46.67K |
| Total | +46.67K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
210K shares
Shares
+210K
Strike price
10.19
Held after
210K
Exercisable
—
3/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock210K shares | 3/10/2026 | A · Award | +210K | 10.19 | — | 210K |